Vaccine Therapy in Treating Patients With Head and Neck Cancer

Completed · Phase 1

Conditions studied: Head and Neck Cancer

In brief

RATIONALE: Vaccines made from a person's dendritic cells mixed with peptides may help the body build an effective immune response to kill tumor cells. PURPOSE: This randomized phase I trial is studying the side effects of vaccine therapy in treating patients with head and neck cancer.

Key facts

Study ID

NCT00404339

Run by

Robert Ferris

People needed

17

Starts

2005-09-01

Expected to finish

2014-03-01

Last updated by the study team

2016-04-18

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• UPMC Cancer Centers — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.